UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overview of the 8th Edition TNM Classification for Head and Neck Cancer

Current treatment options in oncology, 2017-07, Vol.18 (7), p.40-40, Article 40

2017

Volltextzugriff (PDF)

Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer

Molecular therapy, 2017-11, Vol.25 (11), p.2440-2451

2017

Volltextzugriff (PDF)

Weekly Volume and Dosimetric Changes During Chemoradiotherapy With Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Observational Study

International journal of radiation oncology, biology, physics, 2010-04, Vol.76 (5), p.1360-1368

2010

Volltextzugriff (PDF)

PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas

Cancer Immunology, Immunotherapy, 2020-10, Vol.69 (10), p.2089-2100

2020

Volltextzugriff (PDF)

Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

International journal of radiation oncology, biology, physics, 2009-12, Vol.75 (5), p.1493-1500

2009

Volltextzugriff (PDF)

Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer

World journal of surgery, 2012-03, Vol.36 (3), p.617-622

2012

Volltextzugriff (PDF)

Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer

Molecular imaging and biology, 2020-02, Vol.22 (1), p.156-164

2020

Volltextzugriff (PDF)

Current Treatment Options for Metastatic Head and Neck Cancer

Current treatment options in oncology, 2012-03, Vol.13 (1), p.35-46

2012

Volltextzugriff (PDF)

Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma

Journal of cancer research and clinical oncology, 2024-05, Vol.150 (5), p.240-240, Article 240

2024

Volltextzugriff (PDF)

Salvage Reirradiaton With Stereotactic Body Radiotherapy for Locally Recurrent Head-and-Neck Tumors

International journal of radiation oncology, biology, physics, 2011-09, Vol.81 (1), p.104-109

2011

Volltextzugriff (PDF)

Post-traumatic stress in head and neck cancer survivors and their partners

Supportive care in cancer, 2018-09, Vol.26 (9), p.3003-3011

2018

Volltextzugriff (PDF)

Bioelectrical phase angle at diagnosis as a prognostic factor for survival in advanced head and neck cancer

European archives of oto-rhino-laryngology, 2018-09, Vol.275 (9), p.2379-2386

2018

Volltextzugriff (PDF)

Cognitive Functioning After Radiotherapy or Chemoradiotherapy for Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2011-09, Vol.81 (1), p.126-134

2011

Volltextzugriff (PDF)

A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer

Modern pathology, 2011-10, Vol.24 (10), p.1295-1305

2011

Volltextzugriff (PDF)

All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma

Annals of surgical oncology, 2019-07, Vol.26 (7), p.2294-2303

2019

Volltextzugriff (PDF)

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)

Cancer Immunology, Immunotherapy, 2021-03, Vol.70 (3), p.743-753

2021

Volltextzugriff (PDF)

Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery

Journal of cancer research and clinical oncology, 2020-05, Vol.146 (5), p.1343-1350

2020

Volltextzugriff (PDF)

Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases

European archives of oto-rhino-laryngology, 2018-03, Vol.275 (3), p.815-821

2018

Volltextzugriff (PDF)

CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment

European archives of oto-rhino-laryngology, 2024-06, Vol.281 (6), p.3143-3156

2024

Volltextzugriff (PDF)

Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma

Medical oncology (Northwood, London, England), 2019-02, Vol.36 (2), p.21-10, Article 21

2019

Volltextzugriff (PDF)

Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic

European archives of oto-rhino-laryngology, 2022-02, Vol.279 (2), p.1111-1115

2022

Volltextzugriff (PDF)

Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

European journal of nuclear medicine and molecular imaging, 2011-07, Vol.38 (7), p.1203-1211

2011

Volltextzugriff (PDF)

European white paper: oropharyngeal dysphagia in head and neck cancer

European archives of oto-rhino-laryngology, 2021-02, Vol.278 (2), p.577-616

2021

Volltextzugriff (PDF)

Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients

PloS one, 2017-04, Vol.12 (4), p.e0175755-e0175755

2017

Volltextzugriff (PDF)

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Cancer Immunology, Immunotherapy, 2017-05, Vol.66 (5), p.573-579

2017

Volltextzugriff (PDF)

1 – 25 von 6.270

Suche als RSS-Feed

Aktive Filter

ThemaMedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.130)
Mit Volltextzugriff
(6.146)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overview of the 8th Edition TNM Classification for Head and Neck Cancer

Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer

Weekly Volume and Dosimetric Changes During Chemoradiotherapy With Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Observational Study

PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas

Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer

Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer

Current Treatment Options for Metastatic Head and Neck Cancer

Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma

Salvage Reirradiaton With Stereotactic Body Radiotherapy for Locally Recurrent Head-and-Neck Tumors

Post-traumatic stress in head and neck cancer survivors and their partners

Bioelectrical phase angle at diagnosis as a prognostic factor for survival in advanced head and neck cancer

Cognitive Functioning After Radiotherapy or Chemoradiotherapy for Head-and-Neck Cancer

A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer

All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)

Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery

Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases

CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment

Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma

Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic

Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

European white paper: oropharyngeal dysphagia in head and neck cancer

Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Aktive Filter

Suchergebnisse filtern